These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25714249)
1. Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases. Yan Y; Li J; Han J; Hou N; Song Y; Dong L Anticancer Drugs; 2015 Jun; 26(5):540-6. PubMed ID: 25714249 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound. Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814 [TBL] [Abstract][Full Text] [Related]
3. Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo. Yan Y; Liu N; Hou N; Dong L; Li J J Nutr Biochem; 2017 Aug; 46():68-73. PubMed ID: 28458139 [TBL] [Abstract][Full Text] [Related]
4. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. Zou X; Liang J; Sun J; Hu X; Lei L; Wu D; Liu L J Pharmacol Sci; 2016 Aug; 131(4):233-40. PubMed ID: 27177453 [TBL] [Abstract][Full Text] [Related]
5. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645 [TBL] [Abstract][Full Text] [Related]
6. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma. Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534 [TBL] [Abstract][Full Text] [Related]
7. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. Refolo MG; Lippolis C; Carella N; Cavallini A; Messa C; D'Alessandro R Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783729 [TBL] [Abstract][Full Text] [Related]
8. Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells. Hou N; Liu N; Han J; Yan Y; Li J Anticancer Drugs; 2017 Jan; 28(1):59-65. PubMed ID: 27603595 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of (-)-epicatechin and chlorogenic acid on the regulation of the apoptotic and survival/proliferation pathways in a human hepatoma cell line. Granado-Serrano AB; Martín MA; Izquierdo-Pulido M; Goya L; Bravo L; Ramos S J Agric Food Chem; 2007 Mar; 55(5):2020-7. PubMed ID: 17286412 [TBL] [Abstract][Full Text] [Related]
10. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling. Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634 [TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells. Sapio L; Salzillo A; Illiano M; Ragone A; Spina A; Chiosi E; Pacifico S; Catauro M; Naviglio S J Cell Physiol; 2020 Apr; 235(4):3741-3752. PubMed ID: 31602671 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production. Sung MW; Lee DY; Park SW; Oh SM; Choi JJ; Shin ES; Kwon SK; Ahn SH; Kim YH Laryngoscope; 2017 Apr; 127(4):E117-E123. PubMed ID: 27666139 [TBL] [Abstract][Full Text] [Related]
13. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Yang L; Wu D; Luo K; Wu S; Wu P Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688 [TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma. Hu XY; Liang JY; Guo XJ; Liu L; Guo YB Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523 [TBL] [Abstract][Full Text] [Related]
15. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines. Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659 [TBL] [Abstract][Full Text] [Related]
16. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma. Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585 [TBL] [Abstract][Full Text] [Related]
17. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway. Fan C; Chen J; Wang Y; Wong YS; Zhang Y; Zheng W; Cao W; Chen T Free Radic Biol Med; 2013 Dec; 65():305-316. PubMed ID: 23837948 [TBL] [Abstract][Full Text] [Related]
18. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552 [TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. Mehdizadeh A; Somi MH; Darabi M; Jabbarpour-Bonyadi M Mol Biol Rep; 2016 Feb; 43(2):107-16. PubMed ID: 26767647 [TBL] [Abstract][Full Text] [Related]
20. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells. Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]